Who Paid My Doc Search
Menu
Organisation paid for research Program year 2022 Source: CMS Open Payments

Novum Pharmaceutical Research Services

Neither a doctor nor a teaching hospital

Research payments

$2,454,349

37 payments

Through program year 2022, Novum Pharmaceutical Research Services is reported as receiving $2,454,349 in research payments, across 37 payments.

By program year

4 rows
Year Kind Amount Payments
2022 Research $477,138 6
2021 Research $1,420,241 19
2020 Research $114,060 4
2019 Research $442,910 8

Breakdown

Who paid Research payments · program years 2019–2022
  1. Apotex Inc. $1,483,820 18 payments
  2. Alvogen Inc $383,429 6 payments
  3. Almatica Pharma LLC $246,750 5 payments
  4. Merck Sharp & Dohme Corporation $201,910 5 payments
  5. Sandoz Inc. $104,060 1 payment
  6. Dr.Reddy's Laboratories,Inc. $34,380 2 payments
Studies the money was for Research payments · program years 2019–2022
  1. 12118701 (Lcn17660) $1,173,050 9 payments
  2. A Randomized, Open-Label, Parallel-Design, One-Period, Two Treatment, Pilot Relative Bioavailability Study of Baloxavir Marboxil Tablets, 40 MG Manufactured By Norwich Pharmaceuticals Inc, Ny 13815 and Xofluza (Baloxavir Marboxil) Tablets, 40 MG Manufactured By Shionogi Pharma Co., Ltd., Japan in Healthy Adult Subjects Under Fasting Conditions $383,429 6 payments
  3. A Randomized, Open-Label, Two-Sequence, Two-Period, Two-Treatment Crossover Study to Evaluate the Effect of Food on the Bioavailability of Once-Daily Venb XR (Venlafaxine Besylate) Extended-Release Tablets, 112.5 MG (Manufactured By Norwich Pharmaceuticals Inc. for Almatica Pharma, LLC) in Healthy Adult Subjects $246,750 5 payments
  4. By10526 $206,620 1 payment
  5. A two-period fixed sequence study to evaluate the effects of pyrimethamine, a potent inhibitor of MATE1,2K, on the pharmacokinetics of MK-7264 in healthy adults $201,910 5 payments
  6. Bioequivalence Study of Calcipotriene and Betamethasone Dipropionate Topical Suspension, 0.005%/0.064% $104,060 1 payment
  7. Lido-Topt-05Sb06-2Fa (Lcn17285) $94,150 5 payments
  8. 11840602 A Study to Evaluate the Relative Bioavailability of a Test Nicotine Transdermal System Patch, 21 mg24 hours Dr. Reddy's Laboratories Ltd. Compared to Habitrol nicotine transdermal system patch, 21 mg24 hours Dr. Reddy's Laboratories Inc. in Healthy Adult Subjects $23,780 1 payment
  9. 11840603 A Study to Evaluate the Adhesive Properties of a Test Nicotine Transdermal System Patch, 21 mg24 hours Dr. Reddys Laboratories Ltd. in Healthy Adult Subjects $10,600 1 payment
  10. 12018703 $4,000 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record